Patrick Joseph Grohar MD PhD
Associate Professor of Pediatrics Director of Translational Research Center of Childhood Cancer Research Children’s Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Grohar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Johns Hopkins UniversityResidency, Pediatrics, 2003 - 2006
Wayne State University School of MedicineClass of 2003
Certifications & Licensure
MI State Medical License 2015 - 2025
PA State Medical License 2020 - 2024
TN State Medical License 2011 - 2017
MD State Medical License 2006 - 2012
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- SARC037: a Phase I/II Study to Evaluate the Safety of Trabectedin in Combination with Irinotecan in Ewing Sarcoma Patients Start of enrollment: 2021 Jan 05
Publications & Presentations
PubMed
- Exploiting divergent mechanisms of trabectedin for bone tumors.Zachary P Tolstyka, Patrick J Grohar
Molecular Therapy. Oncology. 2025-06-18 - Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature gene.Florian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, Tobias Faehling, Jing Li
Cancer Communications. 2025-03-15 - Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han
Medrxiv. 2025-01-20
Press Mentions
- AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)April 24th, 2022
- GDF6-CD99 Signaling Regulates Src and Ewing Sarcoma GrowthNovember 3rd, 2020
CHOP Researchers Working Hard to Unlock the Mysteries of Rare Bone CancerNovember 18th, 2019- Join now to see all
Grant Support
- The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factorUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
- The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factorUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
- A collaborative approach to analyze and target the EWS-FLI1 transcription factor in patients with Ewing sarcomaSARC2019–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
